Low Rates of Surgical Recurrence Following Ileocolic Resections for Crohn’s Disease in the Biologic Era
Inflammatory Bowel Diseases · 2025
DOI: 10.1093/ibd/izaf244 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Inflammatory Bowel Diseases, 2025. Verfasst von Hugh L Giddings und 29 weiteren Autor:innen. Beteiligte Einrichtung: Department of Colorectal Surgery, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. Hauptthemen laut MEDLINE: Crohn Disease, Ileum, Colon, Colectomy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Notaras Scholarship of the University of Sydney and Australia, New Zealand Training Board in Colon and Rectal Surgery, University of Sydney.
Abstract (Originalsprache)
Background
Ileocolic resections (ICRs) are the most common resections for Crohn’s disease. Historical control groups have often been used for comparison when assessing postoperative recurrence, usually with temporal bias. This study aimed to (1) report contemporary rates of postoperative recurrence requiring repeat surgery (surgical recurrence at anastomosis [surgical recurrence at the ileocolic resection site (SR-ICR)] or surgical recurrence at any site) and the rates of endoscopic recurrence (ER) in the “biologic era”; and (2) determine risk factors for SR-ICR and ER.
Methods
A retrospective multicenter study involving 12 tertiary Australian centers was performed. Patients (of any age) who had undergone an ICR for Crohn’s disease between 2007 and 2023 were included. Cox proportional hazards modeling was used to evaluate clinicopathological risk factors for SR-ICR and ER (defined as Rutgeerts grade ≥i2b).
Results
Overall, 875 patients were included (mean 38.7 ± 15.1 years, 51% female). Median follow-up was 63.9 months. Rates of SR-ICR were 4.5% (95% confidence interval [CI], 2.8%-6.1%) and 12.8% (95% CI, 8.8%-16.5%) at 5 and 10 years, respectively. Rates of surgical recurrence at any site were 5.6% (95% CI, 3.8%-7.5%) and 15.1% (95% CI, 11.0%-19.1%) at 5 and 10 years, respectively. Early (within 12 months) ER occurred in 24.7%. On multivariable analysis, smoking (adjusted hazard ratio, 3.49; 95% CI, 1.93-6.29) was the only factor significantly associated with SR-ICR. Smoking, positive microscopic margins, and granulomas were associated with ER, and prophylactic therapy and younger age at diagnosis (<17 years) were protective.
Conclusions
The rate of SR at the ileocolic anastomosis in this large Australian cohort was low, recorded to be 1 in 20 at 5 years. Smoking remains the strongest risk factor for both ER and SR. Histopathological factors influence ER and should be considered in future risk prediction models.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Colorectal Surgery, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.
- Surgical Outcomes Research Centre, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.
- Institute of Academic Surgery, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.
- Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.
- Department of Colorectal Surgery, Concord Repatriation General Hospital, Sydney, New South Wales, Australia.
- Department of Gastroenterology and Hepatology, St Vincent's Hospital, Sydney, New South Wales, Australia.
ORCID-Profile: Hugh L Giddings, David Clark, Jennifer Zhang, Abhinav Vasudevan, Lena Thin
Förderung
- Notaras Scholarship of the University of Sydney and Australia
- New Zealand Training Board in Colon and Rectal Surgery
- University of Sydney
- Australia and New Zealand Training Board in Colon and Rectal Surgery
Zitieren
APA
Giddings, H. L., Ng, K. S., Solomon, M. J., Arzivian, A., Haifer, C., Lin, H., Pappas, C., Clark, D., Deacon, A., Radford-Smith, G., Ebrahimi, N., Wu, A., Lewis, M., Lim, R., Zhang, J., Vasudevan, A., Demase, K., Karp, J., Fernandes, R. G., …, & Australia and New Zealand Inflammatory Bowel Disease Consortium (ANZIBDC), Crohn’s Colitis Cure (CCCure), Post Operative Recurrence and Surgical Outcomes follo… (2025). Low Rates of Surgical Recurrence Following Ileocolic Resections for Crohn’s Disease in the Biologic Era. Inflammatory Bowel Diseases. https://doi.org/10.1093/ibd/izaf244
Vancouver
Giddings HL, Ng KS, Solomon MJ, Arzivian A, Haifer C, Lin H, et al. Low Rates of Surgical Recurrence Following Ileocolic Resections for Crohn’s Disease in the Biologic Era. Inflammatory Bowel Diseases. 2025. doi:10.1093/ibd/izaf244
BibTeX
@article{Giddings2025,
author = {Giddings, Hugh L and Ng, Kheng-Seong and Solomon, Michael J and Arzivian, Arteen and Haifer, Craig and Lin, Huiyu and Pappas, Christian and Clark, David and Deacon, Anthony and Radford-Smith, Graham and Ebrahimi, Nargus and Wu, Ann and Lewis, Mark and Lim, Roscoe and Zhang, Jennifer and Vasudevan, Abhinav and Demase, Kathryn and Karp, Jadon and Fernandes, Richard G and An, Yoon-Kyo and Ng, Zi Qin and Mackenzie, Scott and Thin, Lena and Greeve, Tessa and Moore, Gregory T and Connor, Susan J and Andrews, Jane M and Sparrow, Miles P and Ghaly, Simon and Australia and New Zealand Inflammatory Bowel Disease Consortium (ANZIBDC), Crohn’s Colitis Cure (CCCure), Post Operative Recurrence and Surgical Outcomes follo…, Australia and New Zealand Inflammatory Bowel Disease Consortium (ANZIBDC), Crohn’s Colitis Cure (CCCure), Post Operative Recurrence and Surgical Outcomes follo…},
title = {Low Rates of Surgical Recurrence Following Ileocolic Resections for Crohn’s Disease in the Biologic Era},
journal = {Inflammatory Bowel Diseases},
year = {2025},
doi = {10.1093/ibd/izaf244}
}
EUVIMED